| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |